Probability of success for active substances to the market 2015
This statistic displays the probability of success for active substances into the market as of 2015. Active substances that are considered 'first patient dose' to market have a 17 percent probability of success. Approximately half of the launches consist of specialty drugs for treatment of cancer, pulmonary arterial hypertension, and HIV. New molecular entities have a active moiety that have yet to be approved by the FDA or marketed in the United States.
